Website unlawfully selling versions of Novo Nordisk weight loss drugs gets USFDA warning Ruchika Sharma3 July 2024 6:45 PM ISTThe U.S. Food and Drug Administration (USFDA) said on tuesday it had issued a warning against a website called ozempen.com for illegally selling...
Boosting local manufacturing: India plans incentives for diabetes, obesity drug makers in 2026 Ruchika Sharma29 Jun 2024 12:57 PM ISTBengaluru: India is set to provide incentives aimed at boosting domestic production of GLP-1 drugs, which are utilized to manage diabetes and...
WHO, Eli Lilly warn against fake versions of popular weight loss, diabetes drugs Ruchika Sharma22 Jun 2024 4:46 PM ISTGeneva: The World Health Organization (WHO) and pharmaceutical company Eli Lilly and Co. are cautioning the public about fake versions of popular...
Biocon quest for partner in China to test generic versions of Novo Nordisk Wegovy, Ozempic Ruchika Sharma21 Jun 2024 3:56 PM ISTShanghai: Biocon is looking for a partner in China to test generic versions of Novo Nordisk's weight loss treatment Wegovy and diabetes...
GLP-1 receptor agonist drugs effective but come with complex concerns shows Research Dr. Kamal Kant Kohli12 Jun 2024 8:45 AM ISTDrugs like Ozempic, Wegovy and Mounjaro have been around for years, but they've recently been making headlines due to a rise in popularity as weight...
Cipla open to collaborate with Eli Lilly to market its obesity drugs in India: CEO Ruchika Sharma11 May 2024 11:30 AM ISTBengaluru: The CEO of Cipla on friday expressed openness to collaborate with U.S. pharmaceutical company Eli Lilly for the marketing of their...
Use of Popular obesity drugs may increase risk of aspiration pneumonia following endoscopy: Study Dr. Kamal Kant Kohli28 March 2024 6:00 AM ISTUse of Popular obesity drugs may increase risk of aspiration pneumonia following endoscopy, suggests new research from Cedars-Sinai. Therefore...
Semaglutide 1.0 mg tied to 24% reduction in kidney events among people with type 2 diabetes and CKD: FLOW Trial Medha Baranwal12 March 2024 11:30 PM ISTDenmark: Topline results of the FLOW trial showed a 24% reduction in the risk of kidney disease-related events among patients with type 2 diabetes...
Working with several countries authorities to tackle counterfeit versions of Ozempic: Novo Nordisk CEO Ruchika Sharma10 March 2024 12:15 PM ISTDenmark: Novo Nordisk's CEO on Friday said the company was working with authorities in several countries to tackle counterfeit versions of its popular...
Diabetes drugs can also reduce the risk of severe liver disease Niveditha Subramani25 Jan 2024 3:56 PM ISTReportedly 80% of patients with liver cirrhosis may have glucose metabolism disorders, 30% show overt diabetes mellitus. Both the metabolic disorder...
3 US cases of hypoglycemia linked to suspected fake Ozempic Ruchika Sharma25 Jan 2024 12:45 PM ISTThree people sought medical treatment for dangerously low blood sugar in the U.S. last year after taking suspected fake versions of Novo Nordisk's...
Ozempic not linked to increase in suicidal thoughts: US study Roshni Dhar12 Jan 2024 4:56 PM ISTA recent U.S. federal study funded by the National Institutes of Health (NIH) and conducted by Case Western Reserve University reveals that...
